Article
Genetic background controls tumor development in PTEN-deficient mice.
Cancer research - 1 Jul 2006
Freeman Dan, Lesche Ralf, Kertesz Nathalie, Wang Shungyou, Li Gang, Gao Jing, Groszer Matthias, Martinez-Diaz Hilda, Rozengurt Nora, Thomas George, Liu Xin, Wu Hong
Abstract excerpt
PTEN is one of the most frequently mutated tumor suppressor genes in human cancers. Germ line mutations of PTEN have been detected in three rare autosomal-dominant disorders. However, identical mutations in the PTEN gene may lead to different symptoms that have traditionally been described as different disorders, such as Cowden disease, Lhermitte-Duclos disease, and Bannayan-Zonana syndromes. This lack of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
